⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 27, 2024BMC MedicineOpen Access

Myocardial bridging in obstructive hypertrophic cardiomyopathy: a risk factor for myocardial fibrosis

Changpeng Song Shengwei Wang Xinli Guo Manyun Huang Xinxin Zheng Jie Lu Keshan Ji Shihua Zhao Jingang Cui Shuiyun Wang Xiaohong Huang

View Full Paper

Ask AI

Bookmark

Share

Abstract

Myocardial bridging (MB) is common in patients with hypertrophic cardiomyopathy (HCM). There are sparse data on the impact of MB on myocardial fibrosis in HCM. This study was designed to evaluate the relationship between MB and myocardial fibrosis in patients with obstructive HCM.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Song et al. (2024) studied this question.

synapsesocial.com/papers/68e77584b6db6435876ea9a6 https://doi.org/10.1186/s12916-024-03301-6

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Hemodynamic effects of myocardial bridging in patients with hypertrophic cardiomyopathyother · 2019 · 34 citations
2Exploring the link between myocardial bridging and left ventricular hypertrophy: Congenital factors or remodelling?2024 · 2 citations
3Myocardial bridging of the left anterior descending coronary artery as a risk factor for atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy: a matched case–control studycase-control · 2021 · 11 citations
4Effect of myocardial bridging on preoperative atrial fibrillation and survival in patients with obstructive hypertrophic cardiomyopathy2024 · 1 citations
5Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac deathcross-sectional · 2009 · 167 citations

More related papers

P4496Myocardial bridging in patients with apical hypertrophic cardiomyopathy2017
Myocardial Bridging Increases the Risk of Adverse Cardiovascular Events in Patients without Coronary Atherosclerosis2024
Frequency and Significance of Coronary Artery Disease and Myocardial Bridging in Patients With Hypertrophic Cardiomyopathy2020

More from BMC Medicine

Biologically informed network-regularized sparse consensus clustering (BioNet-SPACC) identifies a continuous plasma proteomic axis in major depressive disorderMon,
Comparative effectiveness of first-/second-generation EGFR-TKI combination therapy versus third-generation EGFR-TKI monotherapy in untreated locally advanced or metastatic EGFR-mutant NSCLC: a real-world, retrospective study in ChinaMon,